Sign In

Nadia Ahmad

Medical Director at Eli Lilly and Company

Nadia Ahmad is a prominent physician specializing in obesity medicine and currently serves as the Medical Director of Obesity Product Development at Eli Lilly and Company, specifically within the Lilly Diabetes division. Her extensive career spans over 14 years, focusing on clinical development and public health strategies related to obesity management.

Professional Background

  • Current Role: Nadia Ahmad holds the position of Associate Vice President (AVP) Medical Director for Obesity Clinical Development at Eli Lilly, where she has been since December 2022. Prior to this, she served as Senior Medical Director for Obesity Clinical Development from June 2021 to December 2022, and as Senior Medical Advisor from February 2019 to May 2021.12

  • Academic Involvement: She is also a Clinical Instructor at Yale University School of Medicine since July 2020, contributing to the education of future medical professionals in obesity medicine.1

  • Founding Director: Dr. Ahmad is the founding director of the Obesity Medicine Institute, established in Dubai in May 2013, where she focuses on improving obesity care through innovative strategies and education.13

  • Previous Experience: Her prior roles include significant positions at Massachusetts General Hospital and Johnson & Johnson, where she developed programs aimed at enhancing obesity treatment delivery across various healthcare systems.3

Education

Dr. Ahmad received her medical degree (MD) from the New York University School of Medicine in 2003, followed by a residency in Internal Medicine at the University of Pennsylvania Health System. She also holds a Master of Public Health (MPH) from the Harvard School of Public Health, completed in 2010.12

Research and Contributions

Dr. Ahmad's research interests include:

  • Developing multimodal treatment protocols for obesity.
  • Exploring the biological mechanisms underlying obesity.
  • Enhancing clinical pathways for effective obesity management.

She has published extensively on topics related to obesity medicine and has been involved in various national and international discussions regarding obesity treatment strategies.34

Certifications and Honors

Dr. Ahmad is board certified in both Internal Medicine and Obesity Medicine. She has received numerous awards throughout her career, including the prestigious Alpha Omega Alpha Award for academic excellence during her medical training.13

In summary, Nadia Ahmad is a key figure in the field of obesity medicine, contributing significantly to clinical practice, education, and research aimed at improving outcomes for individuals affected by obesity.

Highlights

Feb 14 · contactout.com
Nadia Ahmad Email & Phone Number | Eli Lilly and Company
Jun 23 · edition.cnn.com
Daily pill from Eli Lilly leads to 15% weight loss in mid-stage study ...
Apr 27 · nzherald.co.nz
Powerful new obesity drug tirzepatide from Eli Lilly set to upend ...

Related Questions

What are Nadia Ahmad's key achievements in obesity medicine?
How has Nadia Ahmad contributed to obesity treatment at Eli Lilly and Company?
What is Nadia Ahmad's educational background?
What roles has Nadia Ahmad held at Harvard and Yale?
How has Nadia Ahmad's work impacted global obesity management?
Nadia Ahmad
Nadia Ahmad, photo 1
Nadia Ahmad, photo 2
Add to my network

Location

New York City Metropolitan Area